Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Regentis Biomaterials Ltd. (RGNT)

Bionano Genomics, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $15.4M against $8.2M — 1.9× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 8 and Bionano Genomics, Inc. on 1.

Valuation

Metric BNGO RGNT Medical Instruments & Supplies median
P/E n/m — 30.84
P/S 0.44 — 2.54
P/B 0.42 n/m 2.36
Price to free cash flow n/m n/m 23.46
EV/EBITDA n/m n/m 14.70
EV/Sales 0.68 n/m 2.78
Earnings yield (329.80%) — 0.25%
Free cash flow yield (156.38%) 0.00% 0.57%

Profitability

Metric BNGO RGNT Medical Instruments & Supplies median
Gross margin 47.51% — 53.46%
Operating margin (106.67%) — 2.26%
Net margin (106.58%) — 0.16%
Free cash flow margin (67.87%) 0.00% 4.10%
Return on equity (83.56%) 0.00% 0.00%
Return on assets (52.04%) 0.00% 0.00%
Return on invested capital (81.68%) 0.00% 0.13%

Growth

Metric BNGO RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% — 8.97%
EPS growth (last fiscal year) 94.50% (1,504.65%) 6.51%
Revenue growth, 5-year CAGR 27.37% — 8.85%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BNGO RGNT Medical Instruments & Supplies median
Debt to equity 0.11 0.00 0.10
Current ratio 2.48 5.62 2.42
Net debt to EBITDA 1.06 0.89 0.97

Dividend

Metric BNGO RGNT Medical Instruments & Supplies median
Dividend yield — — 1.03%
Payout ratio — — 0.25

Size

Metric BNGO RGNT Medical Instruments & Supplies median
Market cap 15.37m 8.22m 1.64b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack